carbazilquinone has been researched along with Leukemia, Lymphocytic in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshikawa, H | 1 |
| Sao, H | 1 |
| Tahara, T | 1 |
| Akao, Y | 1 |
| Yoshikawa, S | 1 |
1 other study available for carbazilquinone and Leukemia, Lymphocytic
| Article | Year |
|---|---|
[A case of refractory acute lymphocytic leukemia who achieved a complete remission by mitoxantrone].
Topics: Adult; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cyclophospha | 1984 |